The lithotripsy market size is projected to reach US$ 2.3 billion by 2031 from US$ 1.4 billion in 2023. The market is expected to register a CAGR of 6.6% during 2023–2031. Preference for lithotripsy technique in coronary lesion treatment is likely to remain one of the key trends in the market.
The launch of innovative lithotripsy devices drives the lithotripsy market. In January 2022, Olympus announced the launch of its next-generation SOLTIVE Premium SuperPulsed Laser System (SOLTIVE Laser System). The product offers the potential for short procedure time, better patient outcomes, and low procedure cost as compared to standard Holmium: YAG lithotripsy device.
In India, patients experienced lithotripsy procedures to be cost-beneficial. The ED Treatment India website states that the cost of lithotripsy in the country is approximately 40–70% lower than in the US and other developed nations. Additionally, the hospitals in India providing lithotripsy are highly competitive in terms of facilities and amenities and have experienced and skilled healthcare staff.
India
600–2,500
Canada
4,500–12,400
US
11,500–17,900
UK
2,500–8,500
Turkey
2,100–3,600
Australia
5,000–6,500
Singapore
10,000–20,000
UAE
15,000–30,000
Colombia
7,000–15,000
Indonesia
3,000–5,000
Thailand
4,000–8,000
Malaysia
6,000–12,000
Kuwait
10,000–20,000
Philippines
2,000–4,000
Germany
3,000–6,000
Source: HMSDESK, Website India
Therefore, the low cost of lithotripsy procedures in India is responsible for attracting patients across the globe for treatment under medical tourism, which drives the lithotripsy market.
Surgery is a traditional treatment option for patients suffering from kidney stones. These surgeries include nephrectomy and endoscopic treatment of the urethra. However, in the past few years, several new approaches have been developed such as noninvasive lithotripsy techniques for the treatment of upper urinary tract kidney stones. Patients are gradually shifting toward noninvasive procedures owing to increased awareness. According to the US Centers for Medicare & Medicaid Services, all traditional and noninvasive lithotripsy techniques are medically insured/reimbursed. These noninvasive lithotripsy techniques include extracorporeal shock wave lithotripsy, percutaneous lithotripsy, and transurethral ureteroscopic lithotripsy. Further, a report published by the European Med Tech and IVD Reimbursement Consulting Ltd. in October 2019 revealed that Med-Tech Reimbursement Consulting (MTRC) has released notification for medical reimbursement for lithotripsy procedures, such as extracorporeal shock wave therapy and intracorporeal (endoscopic) lithotripsy, in 11 European Union (EU) countries. These countries include Austria, Belgium, Denmark, England, Germany, Italy, the Netherlands, Norway, Sweden, and Switzerland. Furthermore, peripheral IVL is a new coronary lithotripsy technology that will be reimbursed in outpatient, ambulatory surgical centers (ASCs), and inpatient settings. Therefore, medical coverage/reimbursement for noninvasive lithotripsy procedures leads to an increase in patient visits to specialized lithotripsy centers and hospitals, which contributes to the lithotripsy market growth.
Mobile lithotripsy medical units, commercial tractor-trailers, and coaches are significantly beneficial to patients. These units offer patients a new healthcare service without any requirement to set up a specialized lithotripsy center or additional investment. Patients' experience with mobile lithotripsy services is significantly improving with technological advancements. For example, in June 2021, Mobile Medical announced launching its new state-of-the-art mobile lithotripsy unit. The lithotripter device was successfully removed from the existing lithotripsy center and installed in a cab/mobile truck. Similarly, The Oklahoma Mobile Lithotripsy Associates (OMLA), a subsidiary of Oklahoma Lithotripter Associates, has continued to provide extracorporeal shockwave lithotripsy (ESWL) services to area hospitals through a lithotripsy bus/trailer since 1995. The service began with a single Dornier unit. However, with a rise in technological advancements, the units are now transported to each location in small vans, making accessibility and scheduling noninvasive lithotripsy procedures much more accessible. Currently, mobile lithotripsy service is only available in developed countries, particularly in the US, and is anticipated to grow in other countries if awareness about mobile lithotripsy service is increased worldwide. Thus, the rise in mobile lithotripsy services is anticipated to create lucrative opportunities for the lithotripsy service providers in the coming years.
Key segments that contributed to the derivation of the lithotripsy market analysis are product type, application, and end user.
The geographic scope of the lithotripsy market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the market. Further, Asia Pacific is anticipated to record the highest CAGR in the coming years. In North America, the US accounted for the largest share of the lithotripsy market in 2023. According to the Korean Urological Association report, the prevalence of nephrolithiasis (kidney stone) is significantly high in the US. The BD company website reveals that kidney stones affect 1 in 11 people in the US annually, causing a considerable healthcare burden and high cost of treatment. The length of time from diagnosis to treatment takes approximately 18 days, with ~50% of the patients recommended to perform lithotripsy procedures [the majority are treated with extracorporeal shockwave lithotripsy (ESWL)] by physicians. Additionally, the most commonly recommended noninvasive procedure in the US is lithotripsy. The NewChoiceHealth.com website reveals that the average cost of lithotripsy in the US accounts for approximately US$ 12,800. In addition, as the lithotripsy procedure is an outpatient treatment for kidney stone removal, the prices might vary. The following table represents the Virginia State lithotripsy (outpatient cost vs licensed ambulatory surgical center cost) recorded in 2018.
Central
8,710
5,385
Eastern
6,273
4,547
Northern
9,796
5,898
Northwestern
9,983
7,133
Southwestern
9,435
NA
Source: Virginia Health Information
Patients undergoing lithotripsy noninvasive procedures can apply for medical reimbursement/coverage in the US, which benefits patients and leads to more lithotripsy procedures (in terms of volume). The New York Urology Specialists report website states that kidney stone treatment in the US is covered under health insurance. The insurance benefits the patients in blood testing, urologist (consultation fees), surgical cost of any chosen noninvasive as well as surgical procedure [lithotripsy, ureteroscopy, or percutaneous nephrolithotomy (PCNL), diagnostic imaging cost, and others]. Therefore, with rising incidences of kidney stones among the US population, demand for lithotripsy devices is also increasing, which boosts the volume of procedures in hospitals and specialized centers due to medical reimbursement/coverage benefits.
The regional trends and factors influencing the Lithotripsy Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Lithotripsy Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 1.4 Billion |
| Market Size by 2031 | US$ 2.3 Billion |
| Global CAGR (2023 - 2031) | 6.6% |
| Historical Data | 2021-2022 |
| Forecast period | 2023-2031 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Lithotripsy Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Lithotripsy Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The Lithotripsy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Lithotripsy market are listed below:
The “Lithotripsy Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
The List of Report Companies - Lithotripsy Market
North America dominated the lithotripsy market in 2023.
Medical reimbursement/coverage for noninvasive lithotripsy procedures and the launch of innovative lithotripsy devices are a few factors responsible for the market growth.
Preference for lithotripsy technique in coronary lesion treatment to act as a key future trend for the lithotripsy market.
The estimated value of the lithotripsy market is expected to be US$ 2.2 billion in 2031.
The lithotripsy market is expected to record a CAGR of 6.7% from 2023 to 2031.
Edap Tms SA, Becton Dickinson and Co, Olympus Corp, Cook Medical Holdings LLC, Boston Scientific Corp, Karl Storz SE & Co KG, DirexGroup, Dornier MedTech, ELMED Medical Systems, EMS+, NOVAmedtek, and Potent Medical are the key players in the lithotripsy market.